Our research team also demonstrated that dapagliflozin improved metabolic disorders, normalized the estrous cycle, and restored pulsatile luteinizing hormone (LH) secretion and ovulation in melanocortin-4 receptor knockout (MC4R KO) obese mice (6). The gene discussed is MC4R; the disease is metabolic disease.